{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:59:27Z","timestamp":1787313567678,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>With the development of osteosarcoma treatment, limb salvage surgery is gradually replacing amputation as the primary surgical option. Most pediatric osteosarcomas of the limbs undergo limb-salvage surgery. We aimed to use propensity score matching (PSM) analysis test the difference in cancer-specific mortality (CSM) between amputation and limb-salvage surgery in pediatric patients with Osteosarcoma of the limbs. PSM is a statistical method used to deal with data from an Observational Study. The PSM method is designed to reduce the influence of biases and confounding variables to make a more reasonable comparison between experimental and control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patient information was downloaded from the SEER (surveillance, epidemiology, and End Results) database from 2004 to 2018. We included all primary pediatric osteosarcoma patients who underwent limb salvage or amputation. Multivariate logistic regression models were used to explore the factors influencing patient choice of amputation. Differences in CSM and other causes of mortality (OSM) between limb salvage and amputation were analyzed using cumulative incidence plots and competitive risk regression tests after 1:1 proportional propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,058 pediatric patients with limbs Osteosarcoma were included. Patients who underwent amputations were more likely to be male (OR 1.4,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.024) and more likely to have distant metastasis (OR 2.1,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Before propensity matching, CSM was 1.4 times higher in patients undergoing amputation than in patients undergoing limb salvage (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.017) and 3.4 times higher in OSM (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.007). After adjustment for propensity matching, CSM was 1.5 times higher in patients undergoing amputation than in patients undergoing limb salvage (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.028), but there was no significant difference in OSM (HR 3.2,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.078).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggested that amputation is associated with a 1.5-fold increase in CSM in pediatric patients with limbs Osteosarcoma. Therefore, in the surgical selection of pediatric patients with Osteosarcoma, limb salvage surgery should be the first choice in the absence of other contraindications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2022.817051","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T01:03:48Z","timestamp":1644368628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Jinkui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Zhanghuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-319-07323-1_4","article-title":"Osteosarcoma","volume":"162","author":"Moore","year":"2014","journal-title":"Cancer Treat Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mpo.10403","article-title":"Osteosarcoma in the first decade of life","volume":"41","author":"Nagarajan","year":"2003","journal-title":"Med Pediatr Oncol."},{"key":"B3","first-page":"393","article-title":"Epidemiological data for common bone sarcomas","volume":"11","author":"Qureshi","year":"2010","journal-title":"Asian Pac J Cancer Prev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.semdp.2011.02.003","article-title":"Orthopaedic pathology","volume":"28","author":"Schiller","year":"2011","journal-title":"Semin Diagn Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"627254","DOI":"10.1155\/2012\/627254","article-title":"The genetics of osteosarcoma","volume":"2012","author":"Martin","year":"2012","journal-title":"Sarcoma."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomized controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1093\/annonc\/mdx536","article-title":"Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish group for research on sarcoma (GEIS)","volume":"28","author":"Martin-Broto","year":"2017","journal-title":"Ann Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/cells10010172","article-title":"Future directions in the treatment of osteosarcoma","volume":"10","author":"Smrke","year":"2021","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1200\/JCO.2005.06.031","article-title":"Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and\/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate","volume":"23","author":"Meyers","year":"2005","journal-title":"J Clin Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"151654","DOI":"10.1016\/j.anndiagpath.2020.151654","article-title":"Osteosarcoma: a comprehensive review of management and treatment strategies","volume":"49","author":"Jafari","year":"2020","journal-title":"Ann Diagn Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cppeds.2016.04.002","article-title":"Pediatric malignant bone tumors: a review and update on current challenges, and emerging drug targets","volume":"46","author":"Jackson","year":"2016","journal-title":"Curr Probl Pediatr Adolesc Health Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1002\/cncr.27651","article-title":"Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable Osteosarcoma","volume":"118","author":"Bernthal","year":"2012","journal-title":"Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1302\/0301-620X.97B1.33924","article-title":"Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?","author":"Reddy","year":"2015","journal-title":"Bone Joint J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbo.2017.11.005","article-title":"Advances in limb salvage treatment of Osteosarcoma","volume":"10","author":"Yang","year":"2017","journal-title":"J Bone Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1007\/s11999-017-5273-1","article-title":"Is limb salvage with microwave-induced hyperthermia better than amputation for osteosarcoma of the distal tibia?","volume":"475","author":"Han","year":"2017","journal-title":"Clin Orthop Relat Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/1471-2474-15-453","article-title":"Limb function and quality of life after various reconstruction methods according to tumor location following resection of Osteosarcoma in distal femur","volume":"15","author":"Xu","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0959-8049(00)00362-2","article-title":"The effect of local recurrence on survival in resected Osteosarcoma","volume":"37","author":"Weeden","year":"2001","journal-title":"Eur J Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s00268-016-3500-7","article-title":"Amputation versus limb-salvage surgery in patients with osteosarcoma: a meta-analysis","volume":"40","author":"Han","year":"2016","journal-title":"World J Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s13193-018-0725-y","article-title":"Limb salvage versus amputation in conventional appendicular osteosarcoma: a systematic review","volume":"9","author":"Jauregui","year":"2018","journal-title":"Indian J Surg Oncol."},{"key":"B22","first-page":"1117","article-title":"The surveillance, epidemiology, and end results program: a national resource","volume":"8","author":"Hankey","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2106\/00004623-198668090-00005","article-title":"Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur","volume":"68","author":"Simon","year":"1986","journal-title":"J Bone Joint Surg Am."},{"key":"B25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2106\/00004623-199405000-00004","article-title":"Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. a long-term oncological, functional, and quality-of-life study","volume":"76","author":"Rougraff","year":"1994","journal-title":"J Bone Joint Surg Am."},{"key":"B26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1302\/0301-620X.84B1.0840088","article-title":"Osteosarcoma of the limb. amputation or limb salvage in patients treated by neoadjuvant chemotherapy","volume":"84","author":"Bacci","year":"2002","journal-title":"J Bone Joint Surg Br."},{"key":"B27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","article-title":"Update on survival in osteosarcoma","volume":"47","author":"Anderson","year":"2016","journal-title":"Orthop Clin North Am."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.ejca.2005.08.026","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at rizzoli institute, Italy","volume":"41","author":"Bacci","year":"2005","journal-title":"Eur J Cancer."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1007\/s11999-010-1423-4","article-title":"Does increased rate of limb-sparing surgery affect survival in osteosarcoma?","volume":"468","author":"Ayerza","year":"2010","journal-title":"Clin Orthop Relat Res."},{"key":"B30","first-page":"175","article-title":"Clinical outcome and survival of osteosarcoma patients in cipto mangunkusumo hospital: limb salvage surgery versus amputation","volume":"48","author":"Kamal","year":"2016","journal-title":"Acta Med Indones."},{"key":"B31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejca.2004.11.012","article-title":"Management and outcome after local recurrence of osteosarcoma","volume":"41","author":"Grimer","year":"2005","journal-title":"Eur J Cancer."},{"key":"B32","first-page":"153","article-title":"Survival outcomes of pediatric osteosarcoma and ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007","volume":"38","author":"Schrager","year":"2011","journal-title":"J Registry Manag."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.2106\/JBJS.L.01189","article-title":"Risk factors for metastatic disease at presentation with Osteosarcoma: an analysis of the SEER database","volume":"95","author":"Miller","year":"2013","journal-title":"J Bone Joint Surg Am."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.817051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T01:03:53Z","timestamp":1644368633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.817051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":33,"alternative-id":["10.3389\/fsurg.2022.817051"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.817051","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"817051"}}